Cover |
May 09, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | ProPhase Labs, Inc. (the “Company”) is filing this Amendment No. 1 (this “Amendment”) to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 9, 2024 (the “Original Report”) solely to correct typographical errors in Exhibit 99.1, Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) and corrects (1) the earnings (loss) per share for basic and diluted from $(0.07) to $(0.35), and (2) the weighted average common shares outstanding for basic and diluted from 90,423 to 18,045. A copy of the correct press release is furnished herewith as Exhibit 99.1 to this Amendment. This Amendment does not otherwise amend, update or change any other disclosure contained in the Original Report. |
| Document Period End Date | May 09, 2024 |
| Entity File Number | 000-21617 |
| Entity Registrant Name | PROPHASE LABS, INC. |
| Entity Central Index Key | 0000868278 |
| Entity Tax Identification Number | 23-2577138 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 711 Stewart Avenue |
| Entity Address, Address Line Two | Suite 200 |
| Entity Address, City or Town | Garden City |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 11530 |
| City Area Code | (215) |
| Local Phone Number | 345-0919 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0005 |
| Trading Symbol | PRPH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |